Article info
PDFCurrent controversy
COVID-19 vaccines: a look at the ethics of the clinical research involving children
- Correspondence to Dr Laura Cabiedes-Miragaya, Department of Applied Economics, University of Oviedo, 33006 Oviedo, Spain; LCABIE{at}uniovi.es
Citation
COVID-19 vaccines: a look at the ethics of the clinical research involving children
Publication history
- Received October 16, 2021
- Accepted January 24, 2022
- First published February 10, 2022.
Online issue publication
September 28, 2022
Article Versions
- Previous version (28 September 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage
Other content recommended for you
- Factors, enablers and challenges for COVID-19 vaccine development
- US public investment in development of mRNA covid-19 vaccines: retrospective cohort study
- Global access to COVID-19 vaccines: a scoping review of factors that may influence equitable access for low and middle-income countries
- Comparing research and development, launch, and scale up timelines of 18 vaccines: lessons learnt from COVID-19 and implications for other infectious diseases
- The case for adopting a combined comparative medicine and One Health approach to tackle emerging diseases
- Postmarketing studies: can they provide a safety net for COVID-19 vaccines in the UK?
- Evolving pharmacovigilance requirements with novel vaccines and vaccine components
- Healthcare provider perspectives on COVID-19 vaccination for children in India
- Vaccine nationalism and internationalism: perspectives of COVID-19 vaccine trial participants in the United Kingdom
- Future of covid-19 vaccine pricing: lessons from influenza